The company said that TBIs indicate a change in normal brain function caused by an external force, or trauma, and its new i-STAT Alinity TBI plasma test measures specific proteins present in the blood after a TBI. “You can’t treat what you don’t know and now physicians will be equipped with critical, objective information that will help them provide the best care possible, allowing patients to take steps to recover, prevent re-injury and get back to doing the things they care about most.” The US healthcare company said that the new test is designed to run on its i-STAT Alinity platform, and is claimed to be the first handheld rapid blood test for assessing TBI.Īlso, the test empowers clinicians evaluating people with suspected mild TBIs (concussions) and delivers results within 15 minutes after placing plasma in the test cartridge.Ībbott diagnostics business medical director Beth McQuiston said: “Healthcare providers have been waiting for a blood test for the brain and now we have one. (Credit: Abbott.)Ībbott has secured the US Food and Drug Administration (FDA) 510(k) approval for i-STAT Alinity Plasma Test, a rapid handheld blood test to detect traumatic brain injury (TBI), including concussions. The test is designed to evaluate mild traumatic brain injury (TBI) (concussion) and offer results within 15 minutes after using a plasma sampleĪbbott gets FDA approval for rapid concussions blood test. Flavours, Flavour Enhancers and Fragrances.Carbohydrates, Starches and Wheat Glutens.Packaging Materials, Containers and Containment Services.Brand Protection and Anti-counterfeiting.Active Pharmaceutical Ingredients and Intermediates.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |